StonvexLoading…
StonvexStonvexStonvexCore line items from CARE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.32M | $19.41M | $17.27M | $18.33M |
Operating Income | $40.00M | $30.87M | $28.72M | $61.72M |
Net Income | $31.36M | $24.52M | $23.38M | $50.12M |
EPS (Diluted) | $1.38 | $1.06 | $1.00 | $2.03 |
Total Assets | $4.85B | $4.66B | $4.51B | $4.20B |
Total Liabilities | $4.43B | $4.27B | $4.16B | $3.88B |
Cash & Equivalents | $105.16M | $131.17M | $54.53M | $46.87M |
Free Cash Flow OCF − CapEx | $31.81M | $28.80M | $36.93M | $64.90M |
Shares Outstanding | 22.08M | 23.07M | 22.96M | 23.96M |